Linking TP53 codon 72 and P21 nt590 genotypes to the development of cervical and ovarian cancer
- 1 May 2006
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 42 (7) , 958-963
- https://doi.org/10.1016/j.ejca.2006.01.015
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Linkage of TP53 codon 72 pro/pro genotype as predictive factor for nasopharyngeal carcinoma developmentEuropean Journal Of Cancer Prevention, 2006
- Characterization of HPV genotype profile in squamous cervical lesions in Portugal, a southern European population at high risk of cervical cancerEuropean Journal Of Cancer Prevention, 2005
- The influence of HER2 genotypes as molecular markers in ovarian cancer outcomeBiochemical and Biophysical Research Communications, 2005
- TP53 codon 72 polymorphism and risk for cervical cancer in PortugalCancer Genetics and Cytogenetics, 2005
- Global Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2005
- Cancer incidence and mortality in PortugalEuropean Journal Of Cancer, 2003
- Platinum/paclitaxel-based chemotherapy in advanced ovarian carcinoma: glutathione S -transferase genetic polymorphisms as predictive biomarkers of disease outcomeInternational Journal of Clinical Oncology, 2003
- Epidemiologic Evidence and Human Papillomavirus Infection as a Necessary Cause of Cervical CancerJNCI Journal of the National Cancer Institute, 1999
- p53, the Cellular Gatekeeper for Growth and DivisionCell, 1997
- p53 Mutations in Human CancersScience, 1991